Research Output | Dar Al-hikmah Library | IIUM Only
Introduction Acute kidney injury (AKI) is an independent risk factor that contributes to morbidity and mortality in critically ill patients. Plasma Creatinine is the current marker used to diagnose AKI; however, it is delayed biomarker. Newer marker has been shown to have a faster diagnostic utility. Plasma Cystatin (CysC) is a new functional marke